Presentations: 2008-2023
Invited Speaker: “Real-World Evidence: Leveraging RWD for Clinical and Observational Research.” 15th Annual
Summit for Clinical Ops Executives (SCOPE), February 11-14, 2024, Orlando, FL
Invited Speaker: “Approaches to Enhance Generalizability of Clinical Trials: Real-World Data, Novel Designs
and Digital Solutions.” Clinical Trials Europe, 29th - 30th November 2023, Barcelona, Spain.
Panelist: “Integrating Statistical Innovation in Healthcare Organization.” The Inaugural Statistical
Innovation Community Summit, ASA New York City Chapter, Tarrytown, NY. November 9, 2023
Panelist. “RWE Study Design and Causal Identification.” FIORD 2023. Forum on the Integration of
Observational and Randomized Data Advancing the Integration of Real-World Evidence for Regulatory
Decision-Making. November 6–7, 2023, The National Press Club, Washington DC
Invited Discussant: “Innovative Approaches in Optimizing Real World Evidence in Decision Making and Drug
Development”, Joint Statistical Meetings, Toronto, Canada, August 5-10, 2023.
Special Session: “Toward Enhanced Collaboration among Statisticians of Indian and African Descent in North
America.”2023 International Indian Statistical Association (IISA) Conference, June 1-4, 2023, Colorado School of
Mines, Golden, Colorado USA.
“Recent Developments in Causal Inference and Real-World Evidence Generation”, SCOPE 2023, February 6-9,
Orlando, FL
“Enhancing Generalizability of Clinical Trial Results Through Use of Real-World Evidence and Digital
Solutions to Improve Enrollment Diversity.” Duke Industry StatisticsSymposium (DISS2023), March 30-31, 2023,
Virtual.“Technologies and Innovative Trial Designs to Enhance Trial Population Diversity.” DIA Innovative Trial
Designs Conference , November 3-4, 2022, Tysons Corner, VA.
“Discussion: Recent Developments in Causal Inference with Real World Evidence in Drug Development.” Joint
Statistical Meetings in Washington, DC., August 6-11, 2022.
"Methodological and Related Issues in the Use of Real-World Evidence to Enhance Drug Development.” Summit
for Clinical Ops Executives (SCOPE), February 7-10, 2022, Orlando, FL
"Considerations on the Use of Analytics and Technology to Enhance Diversity in Clinical Trials.” DIA 2021
Annual Meeting, June 27-July 1, 2021, Invited. Virtual.
“Digitizing Clinical Trials to Enhance Diversity.” Joint Statistical Meetings. August 7–12, 2021. Invited.
Virtual.
“Challenges and Opportunities with Decentralized Trials: Statistical Perspectives”,28th
Annual Biopharmaceutical Applied Statistics Symposium (BASS),October 25-28, 2021. Invited. Virtual.
“Generating Reliable Evidence from Large-Scale Healthcare Data”, JSM 2020, InvitedDiscussant
“Considerations on the Use of Real-World Data in Trial Design.” Summit for Clinical Ops Executives
(SCOPE).Orlando, Florida, 18-21 February 2020.
“Trending topics in enhanced clinical research and drug development.” 18th Annual ASA CT Chapter
Mini-Conference. April 21, 2020
“On the Bias and Variance of the Odds Ratio, Relative Risk and False Discovery Proportion.” XV Latin
American Congress of Probability and Mathematical Statistics (CLAPEM 2019). 2-6 December 2019; Merida-Yucatán,
México
“Challenges and Opportunities with Use of Real-World Evidence in Drug Development. Summit for Clinical Ops
Executives (SCOPE): Leveraging RWD for Clinical and Observational Research.Orlando, Florida, 18-21 February
2019.
“Real-World Evidence.” Precision Medicine SAMSI Workshop on Advances in Precision and Personalized
Medicine. Raleigh, NC.14-15 March 2019
“A Leisurely Look at Deep Learning: A Statistician's Perspective.” Pharmaceutical Users Software Exchange.
Collegeville, PA. 17 May 2018.
“Reflections on the Opportunities and Challenges of Big Data. 36th Annual Spring Symposium.” ASA New Jersey
Chapter, Rutgers RWJ Medical School, 29 May 2015, Piscataway, NJ. 29 May 2015
Statistical Issues in the Assessment of Risk and Benefits of Alternative
Treatment Modalities. Invited talk at: International Symposium on
Business and Industrial Statistics (ISBIS 2012) June 17-21, 2012 Bangkok, Thailand
Meta-analysis in Risk-Benefit Evaluation.
Indian Association for Statistics in Clinical Trials (IASCT) Annual
Conference, April 19-22, 2012,
Bangalore, India
Good Research Practices for Nonrandomized Studies of Treatment
Effects Using Secondary Data Sources. Invited talk at: 2nd International Symposium on
Biopharmaceutical Statistics, February 28-March 3, 2011, Berlin, Germany.
Reflections on Heterogeneity and Exchangeability in Comparative Effectiveness Research. Invited talk at: 20th Applied Statistics Symposium,
International Chinese Statistical Association (ICSA ), June 26-29, 2011, New York City, NY
Current Issues with Meta-analysis in Medical Research. Instituto
Panamericano de Estudios Avanzados en Probabilidad y Estadistica, PASI,
Semana de Bioinformatica, Bioestadistica, Analisis de Supervivencia, May 3-8, 2010. Guanajuato, Mexico.
Recent Developments in Indirect Treatment Comparisons. Australian Statistical Conference. December 6-9, 2010. Perth, Australia.
A Comparative Study of Entropy-Based Goodness of Fit Tests. Stellenbosch Statistical Symposium: The International Society for Business and
Industrial Statistic. August 24-26, 2009, Stellenbosch, Republic of South Africa
Enhancing the Statistics Profession Globally Through an Educational
Ambassador Initiative. (Panelist with M. Aliaga and F. Scheuren). The 57th Session of
the International Statistical Institute, August 16-22, 2009, Durban, Republic of South Africa
Testing for Normality Based on Entropy. First Annual Symposium of The International Society for Biopharmaceutical Statistics. June 30 - July 2,
2008, Shanghai, China
Drug Safety Assessment. Discussant of Invited Talks at: First Annual Symposium of The International Society for Biopharmaceutical
Statistics. June 30 - July 2, 2008, Shanghai, China